RE: This mornings’s report25 Nov 2024 20:44
Polarean expects to be profitable once it is generating minimum revenue of US$25m-US$35m and calculates that hospitals will make a profit on their investment in Polarean’s Xenon MRI platform at 3-4 scans per week per
installation.
We estimate the consumables cost per scan at cUS$600, so with Medicare/Medicaid direct reimbursables at cUS$1.3k (Figure 12), the margin is over 50% just from the Xenon-129 specification code with an annual netrevenue potential of US$110k-US$150k per installation. That would roughly
equate to a 5-6 year payback on a new, full priced clinical XENOVIEW®installation. In addition, there would be the potential to increase utilisation,while the reimbursable rate in private use is 1.5x-2.0x that for government
funded healthcare, promising significantly enhanced economics.